__NUXT_JSONP__("/drugs/Stapuldencel-T", (function(a,b,c,d){return {data:[{drug:{slug:b,emaEpar:[],fdaDrugLabel:[],id:b,nciThesaurus:{casRegistry:a,chebiId:a,chemicalFormula:a,definition:"A dendritic cell (DC)-based cancer vaccine composed of autologous dendritic cells (DCs) activated with a prostate tumor cell lysate containing tumor-associated antigens (TAAs) with potential immunostimulatory and antineoplastic activities. Upon administration, stapuldencel-T  may stimulate an anti-tumoral cytotoxic T-lymphocyte (CTL) response against prostate cancer cells expressing prostate tumor cell-specific antigens, which may result in prostate tumor cell lysis.",fdaUniiCode:"RB8MSD888P",identifier:"C115106",preferredName:c,semanticType:"Cell",subclassOf:["C2594"],synonyms:["DCVAC\u002FPCa","Prostate Tumor Antigen-activated Autologous Dendritic Cell Vaccine","STAPULDENCEL",c]},dir:"\u002Fdrugs",path:"\u002Fdrugs\u002FStapuldencel-T",extension:".json",createdAt:d,updatedAt:d}}],fetch:{},mutations:void 0}}("","Stapuldencel-T","Stapuldencel-T ","2021-10-30T13:18:53.313Z")));